The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 04, 2025
Filed:
Oct. 01, 2019
Applicant:
N.v. Nutricia, Zoetermeer, NL;
Inventors:
Mirjam Kuhn, Utrecht, NL;
Maryam Rakhshandehroo, Utrecht, NL;
Assignee:
N.V. Nutricia, Zoetermeer, NL;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/702 (2006.01); A23L 33/00 (2016.01); A23L 33/12 (2016.01); A23L 33/125 (2016.01); A23L 33/135 (2016.01); A23L 33/155 (2016.01); A23L 33/16 (2016.01); A23L 33/175 (2016.01); A23L 33/18 (2016.01); A23L 33/22 (2016.01); A23L 33/24 (2016.01); A61K 31/202 (2006.01); A61K 31/59 (2006.01); A61K 31/715 (2006.01); A61K 31/717 (2006.01); A61K 31/718 (2006.01); A61K 31/733 (2006.01); A61K 31/736 (2006.01); A61K 33/06 (2006.01); A61K 35/745 (2015.01); A61K 35/747 (2015.01); A61P 7/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/702 (2013.01); A23L 33/12 (2016.08); A23L 33/125 (2016.08); A23L 33/135 (2016.08); A23L 33/155 (2016.08); A23L 33/16 (2016.08); A23L 33/175 (2016.08); A23L 33/18 (2016.08); A23L 33/22 (2016.08); A23L 33/24 (2016.08); A23L 33/40 (2016.08); A61K 31/202 (2013.01); A61K 31/59 (2013.01); A61K 31/715 (2013.01); A61K 31/717 (2013.01); A61K 31/718 (2013.01); A61K 31/733 (2013.01); A61K 31/736 (2013.01); A61K 33/06 (2013.01); A61K 35/745 (2013.01); A61K 35/747 (2013.01); A61P 7/08 (2018.01); A23V 2002/00 (2013.01);
Abstract
The present invention concerns a composition comprising dietary fiber for use in the dietary management of methylmalonic acidemia (MMA) and/or propionic acidemia (PA), and/or for use in treating and/or reducing MMA and/or PA, and/or treating, reducing and/or preventing symptoms associated therewith.